민기준 조교수
#일반 혈액질환
|
학력
2000~2008 한양대학교 생명과학 학사
2008~2012 경희대학교 의학 석사
2008~2012 경희대학교 의학 석사
경력
2019~현재 서울성모병원 혈액내과 임상진료조교수
논문
2019 Dec
CANCER MEDICINE 공동저자
Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome?negative acute lymphoblastic leukemia in first salvage
2019 Nov
CANCER MEDICINE 공동저자
Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experience
2019 Nov
INTERNATIONAL JOURNAL OF HEMATOLOGY 제1저자
A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation
2019 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
WT1 measurable residual disease assay in patients with acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation: Optimal Time Points, Thersholds, and Candidates
2019 Oct
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia
2019 Sep
BONE MARROW TRANSPLANTATION 공동저자
Excellent outcomes of hematopoietic stem cell transplantation with total nodal irradiation and antithymocyte globulin conditioning in severe aplastic anemia with advanced age and/or severe comorbidity
2019 Aug
SCIENTIFIC REPORTS 공동저자
Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia
2019 Jul
ANNALS OF HEMATOLOGY 공동저자
Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma
2019 Jun
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 공동저자
Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
2019 Mar
CANCER 공동저자
Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia
2019 Feb
INTERNATIONAL JOURNAL OF STEM CELLS 공동저자
Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia
2019 Feb
BONE MARROW TRANSPLANTATION 공동저자
Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas
2019 Jan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
CANCER MEDICINE 공동저자
Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome?negative acute lymphoblastic leukemia in first salvage
2019 Nov
CANCER MEDICINE 공동저자
Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experience
2019 Nov
INTERNATIONAL JOURNAL OF HEMATOLOGY 제1저자
A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation
2019 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
WT1 measurable residual disease assay in patients with acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation: Optimal Time Points, Thersholds, and Candidates
2019 Oct
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia
2019 Sep
BONE MARROW TRANSPLANTATION 공동저자
Excellent outcomes of hematopoietic stem cell transplantation with total nodal irradiation and antithymocyte globulin conditioning in severe aplastic anemia with advanced age and/or severe comorbidity
2019 Aug
SCIENTIFIC REPORTS 공동저자
Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia
2019 Jul
ANNALS OF HEMATOLOGY 공동저자
Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma
2019 Jun
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 공동저자
Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
2019 Mar
CANCER 공동저자
Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia
2019 Feb
INTERNATIONAL JOURNAL OF STEM CELLS 공동저자
Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia
2019 Feb
BONE MARROW TRANSPLANTATION 공동저자
Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas
2019 Jan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
저서
저서 내용이 없습니다.
보도자료
[헬로 굿센터] 서울성모병원 림프종팀, 다른 병원서 재발환자 보내주는 '4차병원' 명성
https://www.sedaily.com/NewsView/1S4LGI4RBO
https://www.sedaily.com/NewsView/1S4LGI4RBO
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.